Re-Evaluations of Zr-DFO Complex Coordination Chemistry for the Estimation of Radiochemical Yields and Chelator-to-Antibody Ratios of (89)Zr Immune-PET Tracers

por Imura, Ryota, Ida, Hiroyuki, Sasaki, Ichiro, Ishioka, Noriko S., Watanabe, Shigeki
Publicado 2021

Anti-tumor effects and potential therapeutic response biomarkers in α-emitting meta-(211)At-astato-benzylguanidine therapy for malignant pheochromocytoma explored by RNA-sequencing...

por Ohshima, Yasuhiro, Kono, Nobuaki, Yokota, Yuichiro, Watanabe, Shigeki, Sasaki, Ichiro, Ishioka, Noriko S., Sakashita, Tetsuya, Arakawa, Kazuharu
Publicado 2019

Enhancing the Therapeutic Effect of 2-(211)At-astato-α-methyl-L-phenylalanine with Probenecid Loading

por Hanaoka, Hirofumi, Ohshima, Yasuhiro, Suzuki, Hiroyuki, Sasaki, Ichiro, Watabe, Tadashi, Ooe, Kazuhiro, Watanabe, Shigeki, Ishioka, Noriko S.
Publicado 2021

Preclinical Evaluation of the Acute Radiotoxicity of the α-Emitting Molecular-Targeted Therapeutic Agent (211)At-MABG for the Treatment of Malignant Pheochromocytoma in Normal Mice...

por Sudo, Hitomi, Tsuji, Atsushi B., Sugyo, Aya, Nagatsu, Kotaro, Minegishi, Katsuyuki, Ishioka, Noriko S., Ito, Hiroshi, Yoshinaga, Keiichiro, Higashi, Tatsuya
Publicado 2019

Highly Efficient Separation of Ultratrace Radioactive Copper Using a Flow Electrolysis Cell

por Sugo, Yumi, Ohira, Shin-Ichi, Manabe, Hinako, Maruyama, Yo-hei, Yamazaki, Naoaki, Miyachi, Ryoma, Toda, Kei, Ishioka, Noriko S., Mori, Masanobu
Publicado 2022

Antitumor effects of radionuclide treatment using α-emitting meta-(211)At-astato-benzylguanidine in a PC12 pheochromocytoma model

por Ohshima, Yasuhiro, Sudo, Hitomi, Watanabe, Shigeki, Nagatsu, Kotaro, Tsuji, Atsushi B., Sakashita, Tetsuya, Ito, Yoichi M., Yoshinaga, Keiichiro, Higashi, Tatsuya, Ishioka, Noriko S.
Publicado 2018

Application of glutathione to roots selectively inhibits cadmium transport from roots to shoots in oilseed rape

por Nakamura, Shin-ichi, Suzui, Nobuo, Nagasaka, Toshinori, Komatsu, Fumiya, Ishioka, Noriko S., Ito-Tanabata, Sayuri, Kawachi, Naoki, Rai, Hiroki, Hattori, Hiroyuki, Chino, Mitsuo, Fujimaki, Shu
Publicado 2013

Nonclinical study and applicability of the absorbed dose conversion method with a single biodistribution measurement for targeted alpha-nuclide therapy

por Sakashita, Tetsuya, Matsumoto, Shojiro, Watanabe, Shigeki, Hanaoka, Hirofumi, Ohshima, Yasuhiro, Ikoma, Yoko, Ukon, Naoyuki, Sasaki, Ichiro, Higashi, Tatsuya, Higuchi, Tetsuya, Tsushima, Yoshito, Ishioka, Noriko S.
Publicado 2021

Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma

por Ohshima, Yasuhiro, Kaira, Kyoichi, Yamaguchi, Aiko, Oriuchi, Noboru, Tominaga, Hideyuki, Nagamori, Shushi, Kanai, Yoshikatsu, Yokobori, Takehiko, Miyazaki, Tatsuya, Asao, Takayuki, Tsushima, Yoshito, Kuwano, Hiroyuki, Ishioka, Noriko S.
Publicado 2016

Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer

por Yamaguchi, Aiko, Achmad, Arifudin, Hanaoka, Hirofumi, Heryanto, Yusri Dwi, Bhattarai, Anu, Ratianto, Khongorzul, Erdene, Shintawati, Rini, Kartamihardja, A. Adhipatria P., Kanai, Ayaka, Sugo, Yumi, S. Ishioka, Noriko, Higuchi, Tetsuya, Tsushima, Yoshito
Publicado 2019

Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer

por Kaira, Kyoichi, Sunose, Yutaka, Ohshima, Yasuhiro, Ishioka, Noriko S, Arakawa, Kazuhisa, Ogawa, Tetsushi, Sunaga, Noriaki, Shimizu, Kimihiro, Tominaga, Hideyuki, Oriuchi, Noboru, Itoh, Hideaki, Nagamori, Shushi, Kanai, Yoshikatsu, Yamaguchi, Aiko, Segawa, Atsuki, Ide, Munenori, Mori, Masatomo, Oyama, Tetsunari, Takeyoshi, Izumi
Publicado 2013